COVID-19 Vaccination During Pregnancy Leads to Improved Neonatal Outcomes Without Increased Maternal Risks
Research shows COVID-19 vaccination during pregnancy reduces infection risk and improves neonatal outcomes without increasing maternal health risks, supporting its safety and efficacy.
Recent research has demonstrated that COVID-19 vaccination during pregnancy offers significant health benefits for both mothers and their newborns, without adding health risks to the mother. An extensive analysis of over 1.2 million pregnant individuals revealed that vaccinated women experienced a 58% reduction in the risk of COVID-19 infection. Additionally, vaccination was linked to a decrease in adverse pregnancy outcomes, including an 8% lower chance of preterm birth before 37 weeks and a 34% reduction in preterm births before 28 weeks.
The study, titled "Safety and Efficacy of Maternal COVID-19 Vaccination During Pregnancy: Umbrella Review & Meta-Analyses," compiled data from 23 meta-analyses encompassing more than 200 studies. Conducted by researcher and Harvard University fellow Nikan Zargarzadeh, the review suggests that vaccination during pregnancy also lowers the risk of stillbirth by 25%, reduces the likelihood of neonatal intensive care admissions by 9%, and decreases the incidence of congenital anomalies by 17%. Importantly, no increased risks were observed concerning maternal health, including hospitalization, intensive care needs, gestational diabetes, hypertension, or pre-eclampsia.
The findings, shared during the American Academy of Pediatrics 2025 National Conference & Exhibition, reinforce the safety and benefits of COVID-19 vaccination for pregnant individuals. These results can provide valuable guidance for healthcare providers and pregnant women making informed vaccination decisions.
Source: https://medicalxpress.com/news/2025-09-covid-vaccination-pregnancy-neonatal-outcomes.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Unveiling How Dendritic Cells Respond to mRNA Vaccines
Belgian scientists uncover how dendritic cells react to mRNA vaccines, revealing insights that could lead to safer and more effective immunizations by directing immune responses precisely.
Understanding the Rise of DNA Testing by Australian Health Insurers
Australian health insurers are now providing DNA tests to predict individual responses to medications, raising important questions about data security, ethical use, and future health screening. Learn what you need to know about this emerging trend.
Innovative Blood Test Detects Multiple Sclerosis Risk Years Before Symptoms Manifest
A novel blood test developed by Vienna researchers can predict multiple sclerosis risk years before symptoms appear by detecting specific antibodies linked to Epstein-Barr virus infection, enabling early diagnosis and intervention.
Fruit Fly Research Links Alzheimer’s Proteins to Systemic Organ Changes and Sensory Decline
New research using fruit fly models uncovers how Alzheimer’s-related proteins Aβ42 and Tau cause widespread organ changes and sensory decline, offering new insights into systemic effects of the disease.